High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea
- Author:
Jee Hyun KONG
1
;
Jae Yeon JANG
;
Tae Hwa KO
;
Seong Hee KANG
;
Yundeok KIM
Author Information
- Publication Type:Letters to the Editor
- From:Blood Research 2022;57(4):290-293
- CountryRepublic of Korea
- Language:English
